Viewing Study NCT00457392


Ignite Creation Date: 2025-12-24 @ 3:18 PM
Ignite Modification Date: 2026-02-03 @ 9:04 AM
Study NCT ID: NCT00457392
Status: COMPLETED
Last Update Posted: 2013-10-29
First Post: 2007-04-04
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone
Sponsor: Pfizer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Non-Small Cell Lung View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-small cell lung cancer View
None sunitinib View
None erlotinib View
None Phase 3 View